Takaya et al. also reported in a cohort of 99 patients with chronic liver disease, equally distributed according to the Child–Pugh score, that ADAMTS-13 activity and antigen were lower in patients with more severe liver disease, and their alteration was directly related to changes in albumin, prothrombin time, and platelet count [127]. The gene discussed is ADAMTS13; the disease is liver disorder.